ENHANCE: A randomized, double-blind, multicenter study comparing magrolimab in combination with azacitidine versus azacitidine plus placebo in treatment-naive patients with higher risk myelodysplastic syndrome
- Kenealy, Melita (Primary Chief Investigator (PCI))
- Baker, Emma (Project Manager)
Project: Research